At a glance
ClinicalIndex Comparison RecordN/ACompleted· 322 enrolled
Drug / intervention
Helmet non-invasive ventilationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Helmet Non-Invasive Ventilation for COVID-19 Patients
King Abdullah International Medical Research Center·interventional·Posted Jul 20, 2020·Updated Sep 9, 2022
In Brief
A clinical study evaluating Helmet non-invasive ventilation for COVID-19 and Acute Hypoxemic Respiratory Failure. Completed, enrolled 322 participants across 1 site.
Detailed Summary
Study hypothesis: Non-invasive positive pressure ventilation delivered by helmet will reduce 28-day all-cause mortality in patients with suspected or confirmed severe COVID-19 pneumonia and acute hypoxemic respiratory failure
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCOVID-19, Acute Hypoxemic Respiratory Failure
CountriesSaudi Arabia
CollaboratorsKing Abdulaziz Medical City, Riyadh, Saudi Arabia, King Fahd Hospital of the University, Al Khobar, Saudi Arabia, Aseer Central Hospital, Abha, Saudi Arabia, King Faisal Specialist Hospital & Research Center, King Fahad Hospital, Madinah, Saudi Arabia, Al Amiri Hospital, Kuwait, King Abdulaziz University, King Saud Medical City
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedJul 2020
Enrollment StartFeb 2021
Primary CompletionNov 2021
Study CompletionJun 2022
TodayJul 2026
First PostedJul 20, 2020
Enrollment StartFeb 8, 2021
Primary CompletionNov 16, 2021
Study CompletionJun 30, 2022
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 6.0 years ago
Interventions
Helmet non-invasive ventilationdevice
Patients will be allocated to helmet non-invasive ventilation